Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry

Basit Öğe Kaydı
dc.authoridBartoletti, Riccardo/0000-0002-0021-0302
dc.authoridCai, Tommaso/0000-0002-7234-3526
dc.authoridKoves, Bela/0000-0001-6886-0750
dc.authorwosidbruyere, franck/ABD-8468-2021
dc.authorwosidBartoletti, Riccardo/HGA-5650-2022
dc.authorwosidCai, Tommaso/AAC-5939-2021
dc.contributor.authorJohansen, Truls E. Bjerklund
dc.contributor.authorZahl, Per-Henrik
dc.contributor.authorBaco, Eduard
dc.contributor.authorBartoletti, Riccardo
dc.contributor.authorBonkat, Gernot
dc.contributor.authorBruyere, Franck
dc.contributor.authorCai, Tommaso
dc.date.accessioned2024-06-12T11:12:58Z
dc.date.available2024-06-12T11:12:58Z
dc.date.issued2020
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground A 68-year-old man died of cerebral arterial embolism 6 days after transrectal prostate biopsy with a single p.o. dose of trimethoprim sulfamethoxazole (TMP-SMX) as prophylaxis. The case precipitated analysis of local antibiotic resistance and complication rates. Materials and methods Data on E. coli resistance from Oslo University Hospital and national data on hospitalizations and mortality after biopsy were retrieved from local microbiology files and the Norwegian Patient Registry (NPR) 2011-2017. Results Urine E. coli resistance against TMP-SMX increased from 35% in 2013 to more than 60% in 2015. For ciprofloxacin, the resistance increased from 15% in 2013 to about 45% in 2016. The highest annual E. coli resistance in blood cultures for TMP-SMX and ciprofloxacin was 37% and 28%, respectively. 10% of patients were hospitalized with a diagnosis of infection within the first 60 days after biopsy and there was a relative increase in mortality rate of 261% within the first 30 days. Due to the severity of the figures, the story and the NPR data were published in Norway's leading newspaper and were succeeded by a series of chronicles and commentaries. Conclusions Several critical points of the biopsy procedure were not performed according to current standards. We believe that the patient might have died of septic embolism after biopsy. As a result of the findings and the debate, local practice was changed from transrectal to transperineal prostate biopsies.en_US
dc.identifier.doi10.1007/s00345-019-02837-0
dc.identifier.endpage26en_US
dc.identifier.issn0724-4983
dc.identifier.issn1433-8726
dc.identifier.issue1en_US
dc.identifier.pmid31183524en_US
dc.identifier.scopus2-s2.0-85067303334en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage17en_US
dc.identifier.urihttps://doi.org/10.1007/s00345-019-02837-0
dc.identifier.urihttps://hdl.handle.net/20.500.14551/23377
dc.identifier.volume38en_US
dc.identifier.wosWOS:000511866800004en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofWorld Journal Of Urologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectProstate Biopsyen_US
dc.subjectComplicationsen_US
dc.subjectHospitalizationen_US
dc.subjectDeathen_US
dc.subjectAntibiotic Resistanceen_US
dc.subjectUrinary-Tract-Infectionsen_US
dc.subjectGlobal Prevalenceen_US
dc.subjectUrology Gpiuen_US
dc.subjectComplicationsen_US
dc.subjectRisken_US
dc.subjectClassificationen_US
dc.subjectDefinitionsen_US
dc.subjectCanceren_US
dc.titleAntibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registryen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu